Affiliation:
1. Department of Pharmaceutical Analysis; China Pharmaceutical University; Nanjing China
2. College of Pharmacy and Chemistry; Dali University; Dali China
3. Research Division of Clinical Pharmacology; the First Affiliated Hospital with Nanjing Medical University; Nanjing China
Funder
National Natural Science Foundation of China
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry
Reference27 articles.
1. Clevidipine butyrate injectable emulsion;Cada;Hospital Pharmacy,2008
2. Screening of stabilizers for LC-MS/MS analysis of clevidipine and its primary metabolite in dog whole blood;Cao;Bioanalysis,2015
3. A 15 years study of the causes of death among elderly hypertensive patients in a hospital-based sample of China;Cui;Archives of Gerontology and Geriatrics,2012
4. Clevidipine - A review of its use in the management of acute hypertension;Deeks;American Journal of Cardiovasc Drugs,2009
5. Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs;Ericsson;Drug Metabolism and Disposition: The Biological Fate of Chemicals,1999
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献